At Vaxcyte, we are driven by our:
To prevent or treat infections caused by bacterial diseases such as pneumococcal disease, Group A Strep and periodontitis.
Sense of Urgency
Bacterial infections remain one of the greatest public health challenges of the 21st century.
Re-engineering the way complex vaccines are
made by leveraging our advanced chemistry platform that goes beyond conventional vaccine development approaches.
We are on a global mission to engineer high-fidelity vaccines that protect humankind from the consequences of bacterial diseases.
“Not since the 1950s has vaccine innovation been as relevant as today. Vaccines are now recognized for the true value they bring in protecting all of us from serious diseases.”
Jim Wassil, Executive Vice President and Chief Operating Officer
Eliminating Invasive Bacterial Infections
A Cause Befitting Our Technology
With our novel technology, we believe we can go beyond traditional vaccine approaches – such as new technologies like mRNA – when it comes to addressing bacterial diseases.
We are working to develop vaccines that improve upon those that are available or forge into new areas where prevention has not been possible. It’s more than incremental change. To me it’s a chance to markedly expand the role vaccines play in treating global health.